pharma news today glp-1 obesity RAs gain popularity as cure for obesity, get explored for NASH, CVDs Weight-loss therapy set to push

Ethics statement This study was determined to be exempt from institutional review board approval by Xiamen Cardiovascular Hospital because it used publicly available, de-identified data

What to bring to your first check-in If you have a follow-up after your first month, bring a simple summary plus the labs you want to ask about

The FDA classifies most compounded semaglutide and tirzepatide formulations as Category C medications, meaning animal reproduction studies have shown adverse effects, but controlled human data is absent

Appetite suppression begins but is usually subtle at starting doses

Exendin-4 and eldecalcitol synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells through M2 macrophages polarization via PI3K/AKT pathway